Name
Apteegikaubanduse Hulgimüük OÜ
Registry code
12590461
VAT number
EE101770145
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
30.12.2013 (10)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| MHM Invest OÜ 12516938 | 50% - 1 250.00 EUR | - | - | |
| Wismo OÜ 14131349 | 50% - 1 250.00 EUR | - | - | |
| Maido Mölder 06.02.1982 (42) | - | Board member | Member of a higher management body, i.e. board member or supervisory board member | |
| Martin Henning 28.08.1975 (49) | - | Board member | Direct ownership | |
| Janno Prants 19.12.1973 (50) | - | - | - | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Farmatar OÜ 14918262 | 80% - 2 000.00 EUR | - | - |
| 2019 02.09.2021 | 2020 06.04.2022 | 2021 13.02.2023 | 2022 27.11.2023 | |
|---|---|---|---|---|
| Total Revenue | 2 598 317 € | 3 471 183 € | 4 615 905 € | 6 359 323 € |
| Net profit (loss) for the period | 44 341 € | 697 209 € | 290 430 € | 472 891 € |
| Profit Margin | 2% | 20% | 6% | 7% |
| Current Assets | 782 403 € | 1 696 784 € | 2 256 742 € | 3 215 331 € |
| Fixed Assets | 13 400 € | 31 583 € | 32 719 € | 92 018 € |
| Total Assets | 795 803 € | 1 728 367 € | 2 289 461 € | 3 307 349 € |
| Current Liabilities | 331 837 € | 597 192 € | 867 856 € | 1 296 678 € |
| Non Current Liabilities | 45 000 € | 15 000 € | 15 000 € | 72 719 € |
| Total Liabilities | 376 837 € | 612 192 € | 882 856 € | 1 369 397 € |
| Share Capital | - | - | - | - |
| Equity | 418 966 € | 1 116 175 € | 1 406 605 € | 1 937 952 € |
| Employees | 4 | 6 | 6 | 7 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 3 418 574.07 € | 128 156.66 € | 35 770.05 € | 8 |
| 2023 Q4 | 4 415 047.04 € | 131 895.49 € | 33 090.57 € | 8 |
| 2023 Q3 | 4 584 536.68 € | 105 893.19 € | 33 098.77 € | 9 |
| 2023 Q2 | 3 216 458.03 € | 77 072.92 € | 29 349.36 € | 6 |
| 2023 Q1 | 3 252 872.57 € | 71 305.29 € | 28 926.34 € | 7 |
| 2022 Q4 | 2 794 681.81 € | 63 477.07 € | 35 084.86 € | 8 |
| 2022 Q3 | 2 148 791.61 € | 67 523.72 € | 28 825.97 € | 8 |
| 2022 Q2 | 2 635 164.3 € | 40 781.38 € | 24 942.86 € | 9 |
| 2022 Q1 | 1 731 790.03 € | 47 910.75 € | 19 538.45 € | 6 |
| 2021 Q4 | 1 991 413.99 € | 72 931.83 € | 20 890.87 € | 6 |
| 2021 Q3 | 1 936 034.29 € | 20 596.82 € | 13 513.44 € | 5 |
| 2021 Q2 | 1 896 233.85 € | 38 097.11 € | 20 865.58 € | 6 |
| 2021 Q1 | 1 282 914.22 € | 26 647.7 € | 15 225.08 € | 7 |
| 2020 Q4 | 1 656 964.51 € | 52 248.3 € | 22 905.57 € | 7 |
| 2020 Q3 | 1 138 479.94 € | 38 638.21 € | 17 602.24 € | 8 |
| 2020 Q2 | 1 770 589.53 € | 44 607.37 € | 18 573.39 € | 8 |
| 2020 Q1 | 1 006 519.55 € | 29 662.83 € | 13 759.1 € | 7 |
